#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous T-cell lymphoma stage II Bulbospinal muscular atrophy congenital Malformation venous Angiosarcoma recurrent Breast cancer Scedosporium infection Albright's disease Leukoencephalopathy Bronchopulmonary dysplasia Cystic fibrosis Hereditary neuropathic amyloidosis Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Myelodysplastic syndrome with excess blasts Restless legs syndrome Lymphangioma More trials…

    Learn about Rare Diseases

    Haemophilia B without inhibitors – Life with Disease Congenital generalised lipodystrophy – Treatment Leiomyosarcoma Glomerulonephritis membranous – Treatment Alternating hemiplegia of childhood – Trials in Disease Paroxysmal nocturnal haemoglobinuria – Diagnostics Mast cell activation syndrome – Trials in Disease Leukoencephalopathy – Treatment Haemolytic uraemic syndrome – Diagnostics Mantle cell lymphoma refractory – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Foscarnet ZUNIBERGENE ROCPARVOVEC Dinoprostone Siplizumab Alternaria Alternata (402) Sulfamethoxazole Cd19-Car_Lenti_Allo Absk021 Hydrochloride Hydrate Interleukin-2 HYDROGEN PEROXIDE FIBRIN Nicotine Rapcabtagene Autoleucel Tetracosactide Efepoetin Alfa Melphalan Hydrochloride Entecavir Bosutinib ATOVAQUONE Vanglusagene Ensiparvovec More therapies…

    Learn about Your Condition

    Prinzmetal angina Pseudomonas infection Migraine with aura Injection site pain Polycystic liver disease Tumour of ampulla of Vater Neurofibrosarcoma Vertebrobasilar stroke Rectal cancer recurrent Bronchostenosis Cutaneous calcification Transferrin decreased Merycism Radiation skin injury Gastrointestinal carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Peritonitis

  • Study on Using Gentamicin and Clindamycin to Prevent Abscesses After Surgery for Complicated Appendicitis in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Appendicitis perforated
    • Complicated appendicitis
    • Peritoneal abscess
    Investigated Drugs:
    • Gentamicin
    • Clindamycin
    The Netherlands

  • Study of caspofungin compared to placebo for treating yeast infections in the abdomen in intensive care unit patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Peritonitis
    • Fungal infection
    Investigated Drugs:
    • Caspofungin
    • Sodium Chloride
    France

  • Study on the Effects of Immunoglobulin A, G, and M in Patients with Peritonitis and Sepsis After Infection Control

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Peritonitis
    • Sepsis
    • Septic shock
    Investigated Drugs:
    • Immunoglobulin A
    • Immunoglobulin G
    • Immunoglobulin M
    Austria Germany

  • Study of intraperitoneal fosfomycin, metronidazole and molgramostim treatment in patients with multi-quadrant peritonitis during abdominal surgery

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Fosfomycin
    • Metronidazole
    • Molgramostim
    Denmark

  • Study on Intraperitoneal Treatment with Fosfomycin, Metronidazole, and Molgramostim for Patients with Multi-Quadrant Peritonitis Undergoing Abdominal Surgery

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Peritonitis
    Investigated Drugs:
    • Fosfomycin
    • Metronidazole
    • Molgramostim
    Denmark

  • Study on Early vs. Delayed Supplementary Parenteral Nutrition with SmofKabiven for Patients After Major Emergency Abdominal Surgery

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Alanine
    • Arginine
    • Calcium Chloride Dihydrate
    Denmark

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!